Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine vs Escitalopram in Cancer-associated Poly-symptomatology
NCT04763135Phase 3Terminated
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirtazapine in major depressive disorder (MDD), sponsored by Hospices Civils de Lyon. Started Dec 2021; status: terminated.
02
Drugs
mirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04763135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04763135.